Table 4.
The Baseline Characteristics Based on Tertiles of the PLR for Patients with Nonparoxysmal AF
| Parameters | T1 (n=110) | T2(n=116) | T3 (n=110) | P value |
|---|---|---|---|---|
| Demographics | ||||
| Age | 65.5±9.9 | 65.9±9.7 | 65.7±10.1 | 0.957 |
| Female sex | 54 (49.1) | 58 (50.0) | 54 (49.1) | 0.988 |
| BMI | 25.4±3.2 | 24.7±3.2 | 25.1±3.2 | 0.341 |
| Current Smoking | 26 (23.6) | 21 (18.1) | 16 (14.5) | 0.220 |
| Previous medical history | ||||
| AF duration | 12 (3, 48) | 12 (4, 60) | 24 (3, 60) | 0.888 |
| Hypertension | 52 (47.3) | 65 (56.0) | 64 (58.2) | 0.227 |
| Diabetes mellitus | 21 (19.1) | 27 (23.3) | 23 (20.9) | 0.741 |
| CHD | 7 (6.4) | 10 (8.6) | 15 (13.6) | 0.170 |
| CHF | 35 (31.8) | 34 (29.3) | 41 (37.3) | 0.430 |
| Previous stroke | 5 (4.5) | 5 (4.3) | 10 (9.1) | 0.270 |
| PAD | 3 (2.7) | 1 (0.9) | 2 (1.8) | 0.707 |
| COPD | 7 (6.4) | 5 (4.3) | 3 (2.7) | 0.431 |
| Laboratory data | ||||
| SBP | 124±17 | 126±17 | 125±19 | 0.803 |
| HR | 77±16 | 77±14 | 81±23 | 0.223 |
| FBG | 5.4±1.0 | 5.4±0.9 | 5.9±1.7 | 0.013 |
| Homocysteine | 14.3±5.8 | 13.5±6.5 | 16.8±12.6 | 0.079 |
| BNP | 180 (94, 318) | 186 (102, 327) | 223 (110, 457) | 0.154 |
| eGFR | 85.2±19.3 | 85.6±17.4 | 81.1±20.0 | 0.148 |
| Alb | 39.9±3.7 | 39.6±5.0 | 39.6±3.9 | 0.853 |
| BUA | 383±117 | 371±91 | 392±106 | 0.330 |
| Cholesterol | 4.05±1.11 | 4.24±1.02 | 4.09±1.03 | 0.409 |
| Triglyceride | 1.41±0.82 | 1.35±0.71 | 1.43±0.71 | 0.739 |
| Platelet | 119±32 | 156±43 | 185±69 | <0.001 |
| Lymphocyte | 2.06±0.71 | 1.67±0.46 | 1.24±0.43 | <0.001 |
| Imaging | ||||
| LAD | 44.1±5.0 | 43.9±4.6 | 45.1±4.8 | 0.121 |
| LVEDd | 47.0±5.6 | 45.9±4.7 | 47.4±6.0 | 0.122 |
| LVEF | 57.7±6.7 | 59.1±4.3 | 55.2±8.7 | <0.001 |
| Discharge medicine | ||||
| Anticoagulant drugs | 104 (94.5) | 112 (96.6) | 106 (96.4) | 0.788 |
| Antiarrhythmic drugs | 96 (87.3) | 104 (89.7) | 95 (86.4) | 0.761 |
| Complications | 11 (10.0) | 11 (9.5) | 16 (14.5) | 0.461 |
| Recurrence | 25 (22.7) | 37 (31.9) | 52 (47.3) | <0.001 |
| CHA2DS2‑VASc score | 2.41±1.59 | 2.51±1.44 | 2.63±1.53 | 0.566 |
| PLR | 59.8±11.6 | 93.8±11.5 | 157.6±46.7 | <0.001 |
Notes: The PLR groups were stratified by the tertiles of the PLR (T1, PLR ≤ 75.6; T2, 75.6 < PLR ≤ 114.9; T3, PLR> 114.9). Data are presented as the mean ± SD, median (IQR), or n (%).
Abbreviations: AF, atrial fibrillation; BMI, body mass index; CHD, coronary heart disease; CHF, chronic heart failure; PAD, peripheral artery disease; COPD, chronic obstructive pulmonary disease; SBP, systolic blood pressure; HR, heart rate; FBG, fasting blood-glucose; BNP, brain natriuretic peptide; eGFR, Estimated glomerular filtration rate; BUA, blood uric acid; Alb, albumin; LAD, left atrial diameter; LVED, left ventricular end diastolic diameter; LVEF, left ventricular ejection fraction; PLR, platelet to lymphocyte ratio.